Neuroprotective role of Convolvulus pluricaulis on aluminium induced neurotoxicity in rat brain

Journal of Ethnopharmacology

Volumn 124, Issue 3, 2009, Pages 409-415

  Bihaqi, Syed Waseem ^a   Sharma, Meenakshi ^b   Singh, Avninder Pal ^c   Tiwari, Manisha ^a  

^a UNIVERSITY OF DELHI   (India)

^b UNIVERSITY OF RHODE ISLAND   (United States)

^c SAFDARJUNG HOSPITAL   (India)

Author keywords

Aluminium chloride; Bax. Convolvulus pluricaulis; Cdk5; M1 receptor; NGF receptor (TrkA)

Indexed keywords

ACETYLCHOLINESTERASE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ALUMINUM CHLORIDE; CONVOLVULUS PLURICAULIS EXTRACT; CYCLIN DEPENDENT KINASE 5; MUSCARINIC M1 RECEPTOR; PLANT EXTRACT; PROTEIN TYROSINE KINASE A; RIVASTIGMINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CONVOLVULACEAE; CONVOLVULUS PLURICAULIS; ENZYME INHIBITION; MALE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PROTEIN EXPRESSION; RAT; UPREGULATION;

ACETYLCHOLINESTERASE; ALUMINUM; ANIMALS; BLOTTING, WESTERN; BODY WEIGHT; BRAIN; BRAIN CHEMISTRY; CEREBRAL CORTEX; CONVOLVULUS; CYCLIN-DEPENDENT KINASE 5; DENSITOMETRY; IMMUNOHISTOCHEMISTRY; INDIA; MALE; NEUROPROTECTIVE AGENTS; NEUROTOXICITY SYNDROMES; ORGAN SIZE; PLANT EXTRACTS; PLANT ROOTS; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

CONVOLVULACEAE; CONVOLVULUS; RATTUS;

EID: 67650683477     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2009.05.038     Document Type: Article

References (43)

1. Bardgett M.E., and Henry J.D. Locomotor activity and accumbens fos expression driven by ventral hippocampal stimulation require D1 and D2 receptors. Neuroscience 94 (1999) 59-70
2. Benzi G., Marzatico F., Pastoris O., and Villa R.F. Relationship between aging, drug treatment and the cerebral enzymatic antioxidant system. Neuroscience Research 24 (1989) 137-148
3. Bhakuni R.S., Tripathi A.K., Shukla Y.N., and Singh S.C. Insect antifeedant constituent from Convolvulus microphyllus (L.) Sieb. Phytotherapy Research 10 2 (1996) 170-171
4. Butterfield D.A., and Lauderback C.M. Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid β-peptide-associated free radical oxidative stress. Free Radical Biology and Medicine 32 (2002) 1050-1060
5. Cutler N.R., Polinsky R.J., and Sramek J.J. Dose-dependent CSF acetylcholine esterase inhibition by SDZ ENA 713 in Alzheimer's disease. Acta Neurologica Scandinavica 97 (1998) 244-250
6. Deloncle R., and Guillard O. Mechanism of Alzheimer's disease: arguments for a neurotransmitter aluminium complex implication. Neurochemical Research 15 (1990) 1239-1245
7. Dignam J.D., Lebovitz R.M., and Roeder R.D. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acid Research 11 (1983) 1475-1489
8. Edwardson J.A., Candy J.M., Ince P.G., McArthur F.K., Morris C.M., Oakley A.E., Taylor G.A., and Bjertness E. Aluminium accumulation, beta-amyloid deposition and neurofibrillary changes in the central nervous system. Ciba Foundation Symposium 169 (1992) 165-179
9. Ellman G.L., Courtney K.D., Andre Jr. V., and Featherstone R.M. A new and rapid colorimetric determination of acetylcholine esterase activity. Biochemical Pharmacology 7 (1961) 88-95
10. Fisher A., Brandeis R., Chapman S., Pittel Z., and Michaelson D.M. M1 muscarinic agonist treatment reverses cognitive and cholinergic impairments of apolipoprotein E-deficient mice. Journal of Neurochemistry 70 5 (1998) 1991-1997
11. Flohé L., and Günzler W. Assays of glutathione peroxidase. In: Packer L. (Ed). Methods in Enzymology vol. 105 (1984), Academic Press 14-120
12. Ghribi O., DeWitt D.A., Forbes M.S., Herman M.M., and Savory J. Co-involvement of mitochondria and endoplasmic reticulum in regulation of apoptosis: changes in cytochrome c, Bcl-2 and Bax in the hippocampus of aluminium-treated rabbits. Brain Research 903 (2001) 66-73
13. Good P.F., Olanow C.W., and Perl D.P. Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: a LAMMA study. Brain Research 593 (1992) 343-346
14. Gulya K., Rakonczay Z., and Kasa P. Cholinotoxic effects of aluminium in rat brain. Journal of Neurochemistry 54 (1990) 1020-1026
15. Habig W.H., Pabst M.J., and Jakoby W.B. Glutathione-S-transferase: the first enzymatic step in mercapturic acid formation. Journal of Biological Chemistry 249 (1974) 7130-7139
16. Horner P.J., and Gage F.H. Regenerating the damaged central nervous system. Nature 407 (2000) 963-970
17. Julka D., and Gill K.D. Altered calcium homeostasis: a possible mechanism of aluminium induced neurotoxicity. Biochemica Biophysica Acta 135 (1996) 47-54
18. Jyoti A., Sethi P., and Sharma D. Bacopa monniera prevents from aluminium neurotoxicity in the cerebral cortex of rat brain. Journal of Ethnopharmacology 111 (2007) 56-62
19. Kurland L.T. Amylotrophic lateral sclerosis and Parkinson's disease complex on Guam linked to an environmental neurotoxin. Trends in Neuroscience 5 (1988) 1151-1158
20. Lapchak P.A., Jenden D.J., and Hefti F. Pharmacological stimulation reveals recombinant human nerve growth factor-induced increases of in vivo hippocampal cholinergic function measured in rats with partial fimbria transections. Neuroscience 50 (1992) 847-856
21. Levey A.I., Sharon M.E., Koliatsos V., Ronald G.W., and Craig J.H. Expression of m1-m4 muscarinic acetylcholine receptor proteins in rat hippocampus and regulation by cholinergic innervation. Journal of Neuroscience 15 5 (1995) 4077-4092
22. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with folin phenol reagent. Journal of Biological Chemistry 193 (1951) 265-275
23. Matyia E. Aluminum enhances glutamate-mediated neurotoxicity in organotypic cultures of rat hippocampus. Folia Neuropathologica 38 2 (2000) 47-53
24. Moron M., Depierre J.W., and Mannervik B.T. Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochimica Biophysica Acta 582 (1979) 67-78
25. Nakayama H., Ginsberg M.D., and Dietrich W.D. (S)-Emopamil, a novel calcium channel blocker and serotonin S2 antagonist, markedly reduces infarct size following middle cerebral artery occlusion in rat. Neurology 38 (1988) 1667-1673
26. Okhawa H., Ohishi N., and Yaga K. Assay of lipid peroxides in animal tissue by thiobarbituric acid reaction. Analytical Biochemistry 95 (1979) 351-358
27. Oosawa H., Fujii T., and Kawashima K. Nerve growth factor increases the synthesis and release of acetylcholine and the expression of vesicular acetylcholine transporter in primary cultured rat embryonic septal cells. Journal of Neuroscience Research 57 (1999) 381-387
28. Paoletti F., and Mocali A. Determination of superoxide dismutase activity by purely chemical system based on NAD(P)H oxidation. In: Packer L., and Glazer A.N. (Eds). Methods in Enzymology vol. 186 (1990), Academic Press 209-220
29. Patrick G.N., Zukerberg L., Nikolic M., de la Monte S., Dikkes P., and Tsai L.H. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 402 (1999) 615-622
30. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1982), Academic Press, New York
31. Rao K.S. Effect of aluminium (Al) on the brain cells of the rat. Biochemistry International 28 1 (1992) 51-60
32. Reznick A.Z., and Packer L. Oxidative damage to proteins: spectrophotometric method for carbonyl assay. In: Packer L. (Ed). Methods in Enzymology vol. 233 (1994), Academic Press 357-363
33. Rocha J.B.T., Emanuelli T., and Pereira M.E. Effects of early under nutrition on kinetic parameters of brain acetylcholinesterase from adult rats. Acta Neurobiologiae Experimentalis 53 (1993) 431-437
34. Shukla S.P. Anti-anxiety agents of plant origin. Probe 20 3 (1981) 201
35. Sinha S.N., Dixit V.P., Madnawat A.V.S., and Sharma O.P. The possible potentiation of cognitive processing on administration of Convolvulus microphyllus in rats. Indian Medicine 1 3 (1989) 1-6
36. Singh G.K., and Bhandari A. Text Book of Pharmacognosy. 1st ed. (2000), CBS Publishers, New Delhi p. 193-194
37. Singh R.H., and Mehta A.K. Studies on the psychotropic effect of the Medhya Rasayana drug 'Shankapushpi' (Convolvulus pluricaulis) Part 1 (clinical studies). Journal of Research in Indian Medicine, Yoga and Homeopathy 12 3 (1977) 18
38. +-ATPase. Protection against lipoperoxidative damage. Biochemical Pharmacology 30 (1981) 427-432
39. Swegert C.V., Dave K.R., and Katyare S.S. Effect of aluminium induced Alzheimer like condition on oxidative energy metabolism in rat liver, brain and heart mitochondria. Mechanism of Ageing and Development 112 (1999) 27-42
40. Urano S., Asai Y., Makabe S., and Matsuo M. Oxidative injury of synapse and alteration of antioxidative defence systems in rats, and its prevention by Vitamin E. European Journal of Biochemistry 245 (1997) 61-70
41. +) ATPase. Toxicology 236 (2007) 158-177
42. Yates C.M., Simpson J., Russell D., and Gordon A. Cholinergic enzymes in neurofibrillary degeneration produced by aluminium. Brain Research 197 (1980) 269-274
43. +-ATPase: the new face of an old player in pathogenesis and apoptotic/hybrid cell death. Biochemical Pharmacology 66 (2003) 1601-1609